Literature DB >> 9344657

Genetic structure and chromosomal mapping of MyD88.

G Hardiman1, N A Jenkins, N G Copeland, D J Gilbert, D K Garcia, S L Naylor, R A Kastelein, J F Bazan.   

Abstract

The myeloid differentiation (MyD) marker MyD88 was initially characterized as a primary response gene, upregulated in mouse M1 myeloleukemic cells in response to differentiation induced by interleukin-6. Subsequent analysis revealed that MyD88 possesses a unique modular structure, which consists of an N-terminal "death domain," similar to the intracellular segments of TNF receptor 1 and Fas, and a C-terminal region related to the cytoplasmic domains of the Drosophila morphogen Toll and vertebrate interleukin-1 receptors. In this report we describe the cloning and gene structure of mouse MyD88. The complete coding sequence of mouse MyD88 spans five exons, with the first exon encoding the complete death domain. Zooblot analysis revealed that MyD88 is an evolutionarily conserved gene. MyD88 was localized to the distal region of mouse chromosome 9 by interspecific backcross mapping. The human homolog (hMyD88) was mapped to chromosome 3p22-p21.3 by PCR analysis of a human chromosome 3 somatic cell hybrid mapping panel. Northern blot analysis revealed widespread expression of MyD88 in many adult mouse tissues, and RT-PCR studies detected MyD88 mRNA in T and B cell lines and differentiating embryonic stem cells. The broad expression pattern demonstrates that mouse MyD88 expression is not restricted to cells of myeloid lineage as was originally believed. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9344657     DOI: 10.1006/geno.1997.4940

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  6 in total

1.  Regulation of MyD88 aggregation and the MyD88-dependent signaling pathway by sequestosome 1 and histone deacetylase 6.

Authors:  Takeshi Into; Megumi Inomata; Shumpei Niida; Yukitaka Murakami; Ken-ichiro Shibata
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

Review 2.  MYD88 Mutations: Transforming the Landscape of IgM Monoclonal Gammopathies.

Authors:  Miguel Alcoceba; María García-Álvarez; Alejandro Medina; Rebeca Maldonado; Verónica González-Calle; María Carmen Chillón; María Eugenia Sarasquete; Marcos González; Ramón García-Sanz; Cristina Jiménez
Journal:  Int J Mol Sci       Date:  2022-05-16       Impact factor: 6.208

Review 3.  MyD88: At the heart of inflammatory signaling and cardiovascular disease.

Authors:  Abraham L Bayer; Pilar Alcaide
Journal:  J Mol Cell Cardiol       Date:  2021-08-08       Impact factor: 5.000

4.  MyD88-5 links mitochondria, microtubules, and JNK3 in neurons and regulates neuronal survival.

Authors:  Younghwa Kim; Ping Zhou; Liping Qian; Jen-Zen Chuang; Jessica Lee; Chenjian Li; Costantino Iadecola; Carl Nathan; Aihao Ding
Journal:  J Exp Med       Date:  2007-08-27       Impact factor: 14.307

Review 5.  Experimental and natural infections in MyD88- and IRAK-4-deficient mice and humans.

Authors:  Horst von Bernuth; Capucine Picard; Anne Puel; Jean-Laurent Casanova
Journal:  Eur J Immunol       Date:  2012-12       Impact factor: 5.532

6.  Mechanism of MyD88S mediated signal termination.

Authors:  Katarzyna Pustelny; Katarzyna Kuska; Andrzej Gorecki; Bogdan Musielak; Ewelina Dobosz; Benedykt Wladyka; Joanna Koziel; Anna Czarna; Tad Holak; Grzegorz Dubin
Journal:  Cell Commun Signal       Date:  2022-01-20       Impact factor: 5.712

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.